INTUITIVE SURGICAL INC — Director's Dealing 2021

Oct 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2021-10-22

Reporting Person: Samath Jamie (SVP of Finance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-22	Common Stock	M	156	$242.3367	Acquired	918	Direct
2021-10-22	Common Stock	S	156	$339.7065	Disposed	762	Direct
2021-10-22	Common Stock	M	156	$177.9867	Acquired	918	Direct
2021-10-22	Common Stock	S	156	$339.6557	Disposed	762	Direct
2021-10-22	Common Stock	M	273	$166.6233	Acquired	1035	Direct
2021-10-22	Common Stock	S	273	$339.6557	Disposed	762	Direct
2021-10-22	Common Stock	M	273	$182.8333	Acquired	1035	Direct
2021-10-22	Common Stock	S	273	$339.6557	Disposed	762	Direct
2021-10-22	Common Stock	M	321	$174.2567	Acquired	1083	Direct
2021-10-22	Common Stock	S	321	$339.6557	Disposed	762	Direct
2021-10-22	Common Stock	M	324	$139.52	Acquired	1086	Direct
2021-10-22	Common Stock	S	324	$339.6557	Disposed	762	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-22	Non-Qualified Stock Option (right to buy)	$139.52	M	324	Disposed	2028-02-15	Common Stock (324)	Direct
2021-10-22	Non-Qualified Stock Option (right to buy)	$166.6233	M	273	Disposed	2029-08-15	Common Stock (273)	Direct
2021-10-22	Non-Qualified Stock Option (right to buy)	$174.2567	M	321	Disposed	2028-08-15	Common Stock (321)	Direct
2021-10-22	Non-Qualified Stock Option (right to buy)	$177.9867	M	156	Disposed	2030-02-28	Common Stock (156)	Direct
2021-10-22	Non-Qualified Stock Option (right to buy)	$182.8333	M	273	Disposed	2029-02-15	Common Stock (273)	Direct
2021-10-22	Non-Qualified Stock Option (right to buy)	$242.3367	M	156	Disposed	2030-08-28	Common Stock (156)	Direct

Footnotes

F1: These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 8, 2021.

F2: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price.

F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.64 to $341.03 as follows: 20 shares sold at $338.64 to $338.99; 106 shares sold at $339.06 to $339.98; 30 shares sold at $340.04 to $341.03. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.47 to $341.34 as follows:179 shares sold at $338.47 to $338.99; 866 shares sold at $339 to $339.99; 280 shares sold at $340.09 to $340.82; 22 shares sold at $341 to $341.34. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F5: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

F6: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48th one month after the date of grant and 1/48th monthly thereafter.

F7: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.